美国FDA生物制品紫皮书数据库（U.S. FDA Purple Book: Database of Licensed Biological Products）- 药物在线

商品名	申请号	产品号	BLA类型	非专利名称	剂型	给药途径	规格/剂量	产品形式	批准日期	申请人	市场状态	许可证状态	参考产品非专利名称	参考产品专利名称
Susvimo	761197	1	351(a)	ranibizumab	Injection	Intravitreal	100MG/ML	Single-Dose Vial	2021/10/22	Genentech, Inc.	Rx	Licensed	N/A	N/A
Dupixent	761055	6	351(a)	dupilumab	Injection	Subcutaneous	100MG/0.67ML	Pre-Filled Syringe	2021/10/20	Regeneron Pharmaceuticals, Inc.	Rx	Licensed	N/A	N/A
Rethymic	125685	1	351(a)	Allogeneic processed Thymus Tissue	For Suspension	Implantation	SEMI-QUANTITATIVE	Dish	2021/10/08	Enzyvant Therapeutics GmbH	Rx	Licensed	N/A	N/A
Sogroya	761156	2	351(a)	somapacitan-beco	Injection	Subcutaneous	5MG/1.5ML (3.3MG/ML)	Autoinjector	2021/10/01	Novo Nordisk Inc.	Rx	Licensed	N/A	N/A
Tivdak	761208	1	351(a)	tisotumab vedotin-tftv	For Injection	Intravenous	40MG	Single-Dose Vial	2021/09/20	Seagen Inc.	Rx	Licensed	N/A	N/A
Byooviz	761202	1	351(k) Biosimilar	ranibizumab-nuna	Injection	Intravitreal	10MG/ML	Single-Dose Vial	2021/09/17	Samsung Bioepis Co., Ltd.	Rx	Licensed	ranibizumab	Lucentis
Skytrofa	761177	1	351(a)	lonapegsomatropin-tcgd	For Injection	Subcutaneous	3MG	Single-Dose Cartridge	2021/08/25	Ascendis Pharma Endocrinology Division A/S	Rx	Licensed	N/A	N/A
Skytrofa	761177	2	351(a)	lonapegsomatropin-tcgd	For Injection	Subcutaneous	3.6MG	Single-Dose Cartridge	2021/08/25	Ascendis Pharma Endocrinology Division A/S	Rx	Licensed	N/A	N/A
Skytrofa	761177	3	351(a)	lonapegsomatropin-tcgd	For Injection	Subcutaneous	4.3MG	Single-Dose Cartridge	2021/08/25	Ascendis Pharma Endocrinology Division A/S	Rx	Licensed	N/A	N/A
Skytrofa	761177	4	351(a)	lonapegsomatropin-tcgd	For Injection	Subcutaneous	5.2MG	Single-Dose Cartridge	2021/08/25	Ascendis Pharma Endocrinology Division A/S	Rx	Licensed	N/A	N/A
Skytrofa	761177	5	351(a)	lonapegsomatropin-tcgd	For Injection	Subcutaneous	6.3MG	Single-Dose Cartridge	2021/08/25	Ascendis Pharma Endocrinology Division A/S	Rx	Licensed	N/A	N/A
Skytrofa	761177	6	351(a)	lonapegsomatropin-tcgd	For Injection	Subcutaneous	7.6MG	Single-Dose Cartridge	2021/08/25	Ascendis Pharma Endocrinology Division A/S	Rx	Licensed	N/A	N/A
Skytrofa	761177	7	351(a)	lonapegsomatropin-tcgd	For Injection	Subcutaneous	9.1MG	Single-Dose Cartridge	2021/08/25	Ascendis Pharma Endocrinology Division A/S	Rx	Licensed	N/A	N/A
Skytrofa	761177	8	351(a)	lonapegsomatropin-tcgd	For Injection	Subcutaneous	11MG	Single-Dose Cartridge	2021/08/25	Ascendis Pharma Endocrinology Division A/S	Rx	Licensed	N/A	N/A
Skytrofa	761177	9	351(a)	lonapegsomatropin-tcgd	For Injection	Subcutaneous	13.3MG	Single-Dose Cartridge	2021/08/25	Ascendis Pharma Endocrinology Division A/S	Rx	Licensed	N/A	N/A
Comirnaty	125742	1	351(a)	COVID-19 Vaccine, mRNA	For Injection	Intramuscular	30UG	Multi-Dose Vial	2021/08/23	BioNTech Manufacturing GmbH	Rx	Licensed	N/A	N/A
Ticovac	125740	1	351(a)	Tick-Borne Encephalitis Vaccine	Injection	Intramuscular	2.4UG/0.5ML	Pre-Filled Syringe	2021/08/13	Pfizer Ireland Pharmaceuticals	Rx	Licensed	N/A	N/A
Ticovac	125740	2	351(a)	Tick-Borne Encephalitis Vaccine	Injection	Intramuscular	1.2UG/0.25ML	Pre-Filled Syringe	2021/08/13	Pfizer Ireland Pharmaceuticals	Rx	Licensed	N/A	N/A
Nexviazyme	761194	1	351(a)	avalglucosidase alfa-ngpt	For Injection	Intravenous	100MG	Single-Dose Vial	2021/08/06	Genzyme Corporation	Rx	Licensed	N/A	N/A
Saphnelo	761123	1	351(a)	anifrolumab-fnia	Injection	Intravenous	300MG/2ML (150MG/ML)	Single-Dose Vial	2021/07/30	AstraZeneca AB	Rx	Licensed	N/A	N/A

药品商品名或专利药名Proprietary (Brand) Name
药品通用名或非专利名称Nonproprietary (Proper) Name
药品申请号BLA Number
产品号Product Number
剂型Dosage Form
给药途径Route of Administration
产品形式Product Presentation
药品规格或剂量Strength
药品注册申请人Applicant
参考产品非专利名称Reference Product Proper Name
参考产品专利名称Reference Product Proprietary Name
BLA类型BLA Type
药品的市场状态Marketing Status
许可证号License Number
许可证状态Licensure
产品批准日期Approval Date	-